These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 24598832)

  • 21. Neonatal lipopolysaccharide treatment has long-term effects on monoaminergic and cannabinoid receptors in the rat.
    Zavitsanou K; Dalton VS; Walker AK; Weickert CS; Sominsky L; Hodgson DM
    Synapse; 2013 Jun; 67(6):290-9. PubMed ID: 23389966
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Evidence for involvement of brain dopamine and other mechanisms in the behavioral action of the N-methyl-D-aspartic acid antagonist MK-801 in control and 6-hydroxydopamine-lesioned rats.
    Criswell HE; Johnson KB; Mueller RA; Breese GR
    J Pharmacol Exp Ther; 1993 May; 265(2):1001-10. PubMed ID: 8098756
    [TBL] [Abstract][Full Text] [Related]  

  • 23. 5-Hydroxytryptamine type 7 receptor neuroprotection against NMDA-induced excitotoxicity is PDGFβ receptor dependent.
    Vasefi MS; Kruk JS; Heikkila JJ; Beazely MA
    J Neurochem; 2013 Apr; 125(1):26-36. PubMed ID: 23336565
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Functional, molecular and pharmacological advances in 5-HT7 receptor research.
    Hedlund PB; Sutcliffe JG
    Trends Pharmacol Sci; 2004 Sep; 25(9):481-6. PubMed ID: 15559250
    [TBL] [Abstract][Full Text] [Related]  

  • 25. 5-HT1A and 5-HT7 receptors contribute to lurasidone-induced dopamine efflux.
    Huang M; Horiguchi M; Felix AR; Meltzer HY
    Neuroreport; 2012 May; 23(7):436-40. PubMed ID: 22415605
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Time course of the development of behavioral sensitization and dopamine receptor up-regulation during binge cocaine administration.
    Unterwald EM; Ho A; Rubenfeld JM; Kreek MJ
    J Pharmacol Exp Ther; 1994 Sep; 270(3):1387-96. PubMed ID: 7932193
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The serotonin 5-HT7 receptor agonist LP-44 microinjected into the dorsal raphe nucleus suppresses REM sleep in the rat.
    Monti JM; Leopoldo M; Jantos H
    Behav Brain Res; 2008 Aug; 191(2):184-9. PubMed ID: 18466985
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Novel biochemical manipulation of brain serotonin reveals a role of serotonin in the circadian rhythm of sleep-wake cycles.
    Nakamaru-Ogiso E; Miyamoto H; Hamada K; Tsukada K; Takai K
    Eur J Neurosci; 2012 Jun; 35(11):1762-70. PubMed ID: 22625848
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The roles of dopamine and serotonin, and of their receptors, in regulating sleep and waking.
    Monti JM; Jantos H
    Prog Brain Res; 2008; 172():625-46. PubMed ID: 18772053
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Selective stimulations and lesions of the rat brain nuclei as the models for research of the human sleep pathology mechanisms].
    Šaponjić J
    Glas Srp Akad Nauka Med; 2011; (51):85-97. PubMed ID: 22165729
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Potentiating action of MKC-242, a selective 5-HT1A receptor agonist, on the photic entrainment of the circadian activity rhythm in hamsters.
    Moriya T; Yoshinobu Y; Ikeda M; Yokota S; Akiyama M; Shibata S
    Br J Pharmacol; 1998 Nov; 125(6):1281-7. PubMed ID: 9863658
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The role of 5-HT7 receptor antagonism in the amelioration of MK-801-induced learning and memory deficits by the novel atypical antipsychotic drug lurasidone.
    Horisawa T; Nishikawa H; Toma S; Ikeda A; Horiguchi M; Ono M; Ishiyama T; Taiji M
    Behav Brain Res; 2013 May; 244():66-9. PubMed ID: 23376699
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cariprazine (RGH-188), a dopamine D(3) receptor-preferring, D(3)/D(2) dopamine receptor antagonist-partial agonist antipsychotic candidate: in vitro and neurochemical profile.
    Kiss B; Horváth A; Némethy Z; Schmidt E; Laszlovszky I; Bugovics G; Fazekas K; Hornok K; Orosz S; Gyertyán I; Agai-Csongor E; Domány G; Tihanyi K; Adham N; Szombathelyi Z
    J Pharmacol Exp Ther; 2010 Apr; 333(1):328-40. PubMed ID: 20093397
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Long-term neuronal damage and recovery after a single dose of MDMA: expression and distribution of serotonin transporter in the rat brain.
    Kirilly E
    Neuropsychopharmacol Hung; 2010 Sep; 12(3):413-23. PubMed ID: 20962361
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects of 2,4-dichlorophenoxyacetic acid exposure on dopamine D2-like receptors in rat brain.
    Bortolozzi AA; Evangelista De Duffard AM; Duffard RO; Antonelli MC
    Neurotoxicol Teratol; 2004; 26(4):599-605. PubMed ID: 15203183
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Stimulation of the parapyramidal region of the neonatal rat brain stem produces locomotor-like activity involving spinal 5-HT7 and 5-HT2A receptors.
    Liu J; Jordan LM
    J Neurophysiol; 2005 Aug; 94(2):1392-404. PubMed ID: 15872068
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Ziprasidone (CP-88,059): a new antipsychotic with combined dopamine and serotonin receptor antagonist activity.
    Seeger TF; Seymour PA; Schmidt AW; Zorn SH; Schulz DW; Lebel LA; McLean S; Guanowsky V; Howard HR; Lowe JA
    J Pharmacol Exp Ther; 1995 Oct; 275(1):101-13. PubMed ID: 7562537
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Liver 5-HT7 receptors: A novel regulator target of fibrosis and inflammation-induced chronic liver injury in vivo and in vitro.
    Polat B; Halici Z; Cadirci E; Karakus E; Bayir Y; Albayrak A; Unal D
    Int Immunopharmacol; 2017 Feb; 43():227-235. PubMed ID: 28043031
    [TBL] [Abstract][Full Text] [Related]  

  • 39. On the mechanism of antidepressant-like action of berberine chloride.
    Kulkarni SK; Dhir A
    Eur J Pharmacol; 2008 Jul; 589(1-3):163-72. PubMed ID: 18585703
    [TBL] [Abstract][Full Text] [Related]  

  • 40. In vitro characterization of SLV308 (7-[4-methyl-1-piperazinyl]-2(3H)-benzoxazolone, monohydrochloride): a novel partial dopamine D2 and D3 receptor agonist and serotonin 5-HT1A receptor agonist.
    Glennon JC; Van Scharrenburg G; Ronken E; Hesselink MB; Reinders JH; Van Der Neut M; Long SK; Feenstra RW; McCreary AC
    Synapse; 2006 Dec; 60(8):599-608. PubMed ID: 17001660
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.